The Mental Retardation Research Center (MRRC) at the University of Alabama at Birmingham (UAB) builds upon UAB's contributions over the past 3 decades to the field of mental retardation and developmental disabilities (MR/DD). The MRRC's mission is threefold: to increase scientific knowledge preventative interventions for MR/DD; and to advance understanding about effective treatment strategies to ameliorate the personnel, familial, and societal consequence of MR/DD. Forty-two investigations from 14 basic science and clinical departments (with 90 funded or pending research projects that will use core supports) will participate. The 6 major Research Groups are: I. Functional synaptic development and plasticity; II. Molecular biology/genetics of nervous system development; III. Neuroendocrinology and infectious disease, IV. Risk conditions and early interventions, V. Low birthweight and prematurity, and VI. Learning, memory, and intelligence. An Administration and Communications Core Unit (Core A) provides scientific leadership, sponsors center-wide scientific seminars and colloquia, encourages innovation and new multi-disciplinary collaborations, actively mentors junior MRRC investigators, and oversees administrative functioning. The four Research Cores are: the Recombinant Technologies Core (Core B), the Simultaneous Laser Scanning Imaging and Electrophysiology Core (Core C), the Longitudinal Studies and Statistical Modeling Core (Core D), and the Developmental Neurobiology Imaging and Tissue Processing Core (Core E). Individually and collectively, these cores are designed to promote multi-disciplinary collaboration, timely exchange of information and technology advances, attract new investigators to MR/DD research, and promote research activities with other MRRCs, as well as to increase the quality and productivity of funded research projects while demonstrating cost- effectiveness. Of high priority is the inclusion of women and individual from under-represented ethnic/racial groups as MRRC scientists, trainees, and participants in research projects.
| Wadsworth, Heather M; Maximo, Jose O; Donnelly, Rebecca J et al. (2018) Action simulation and mirroring in children with autism spectrum disorders. Behav Brain Res 341:1-8 |
| Tarquinio, Daniel C; Hou, Wei; Neul, Jeffrey L et al. (2018) The course of awake breathing disturbances across the lifespan in Rett syndrome. Brain Dev 40:515-529 |
| Killian, John T; Lane, Jane B; Lee, Hye-Seung et al. (2017) Scoliosis in Rett Syndrome: Progression, Comorbidities, and Predictors. Pediatr Neurol 70:20-25 |
| Tarquinio, Daniel C; Hou, Wei; Berg, Anne et al. (2017) Longitudinal course of epilepsy in Rett syndrome and related disorders. Brain 140:306-318 |
| Butler, Anderson A; Webb, William M; Lubin, Farah D (2016) Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction. Epigenomics 8:135-51 |
| Heaven, Michael R; Flint, Daniel; Randall, Shan M et al. (2016) Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease. J Proteome Res 15:2265-82 |
| Robert, Stephanie M; Buckingham, Susan C; Campbell, Susan L et al. (2015) SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci Transl Med 7:289ra86 |
| Parrish, R Ryley; Buckingham, Susan C; Mascia, Katherine L et al. (2015) Methionine increases BDNF DNA methylation and improves memory in epilepsy. Ann Clin Transl Neurol 2:401-16 |
| Tarquinio, Daniel C; Hou, Wei; Neul, Jeffrey L et al. (2015) The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders. Pediatr Neurol 53:402-11 |
| Tarquinio, Daniel C; Hou, Wei; Neul, Jeffrey L et al. (2015) Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosis. Pediatr Neurol 52:585-91.e2 |
Showing the most recent 10 out of 129 publications
